|
FBXL20 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.342600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.008800E-01 |
| Normal-vs-Stage2 |
4.730200E-01 |
| Normal-vs-Stage3 |
9.441500E-04 |
| Normal-vs-Stage4 |
1.190360E-01 |
| Stage1-vs-Stage2 |
1.759040E-01 |
| Stage1-vs-Stage3 |
3.28559999995814E-06 |
| Stage1-vs-Stage4 |
2.440300E-02 |
| Stage2-vs-Stage3 |
6.569500E-02 |
| Stage2-vs-Stage4 |
4.272000E-01 |
| Stage3-vs-Stage4 |
4.797000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.195000E-01 |
| Normal-vs-AfricanAmerican |
5.080300E-02 |
| Normal-vs-Asian |
2.243900E-03 |
| Caucasian-vs-AfricanAmerican |
1.435620E-01 |
| Caucasian-vs-Asian |
3.022000E-02 |
| AfricanAmerican-vs-Asian |
4.181200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.056000E-02 |
| Normal-vs-Female |
6.266600E-01 |
| Male-vs-Female |
3.159700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.004200E-02 |
| Normal-vs-Age(41-60Yrs) |
8.077800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.517600E-02 |
| Normal-vs-Age(81-100Yrs) |
5.277400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.704200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.695400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.794600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.334400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.756600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.698600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.698620E-03 |
| Normal-vs-Grade 2 |
9.835000E-01 |
| Normal-vs-Grade 3 |
3.164400E-01 |
| Normal-vs-Grade 4 |
5.395400E-04 |
| Grade 1-vs-Grade 2 |
2.681900E-02 |
| Grade 1-vs-Grade 3 |
1.614350E-02 |
| Grade 1-vs-Grade 4 |
3.8808999999973E-05 |
| Grade 2-vs-Grade 3 |
2.860200E-01 |
| Grade 2-vs-Grade 4 |
3.369200E-04 |
| Grade 3-vs-Grade 4 |
9.837500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.344040E-01 |
| Normal-vs-ccB subtype |
1.742830E-01 |
| ccA subtype-vs-ccB subtype |
3.856700E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.859600E-01 |
| Normal-vs-N1 |
2.069800E-01 |
| N0-vs-N1 |
2.172200E-01 |
|
|
